CD24 and cancer: Breast CSCs usually express unique cell surface markers referred to as Clusters of Differentiation (CD) and are characterized by the absence or low levels of CD24 and high expression levels of CD44 (CD24−/CD44+), which are frequently utilized to isolate and characterize breast CSCs from cancer cells to understand disease pathology and development of effective anticancer therapeutics.3